How Blood Filtration Works in the Body and Medicine

Blood filtration is the continuous process of separating waste products, toxins, excess fluid, and damaged cells from your bloodstream. Your kidneys do the heavy lifting, processing roughly 180 liters of fluid per day and returning most of it to your circulation while concentrating a liter or two of waste into urine. But the kidneys are not your only filters. Your spleen screens every red blood cell for damage, and your liver traps pathogens before they spread. When disease knocks out kidney function, machines can take over part of the job through dialysis, hemofiltration, or plasma exchange, though none of these technologies replicate the full sophistication of a healthy kidney.

How the Kidneys Filter Blood

Each kidney contains roughly a million tiny filtering units called nephrons. At the start of each nephron sits a structure called the glomerulus, a tuft of capillaries wrapped in a specialized capsule. Blood enters under pressure, and water along with small dissolved molecules gets pushed through a three-layer barrier: the capillary wall, a basement membrane, and a layer of cells called podocytes. Podocytes have finger-like projections that interlock, leaving narrow gaps called filtration slits between them. These slits are bridged by a thin mesh known as the slit diaphragm, which is the key gatekeeper deciding what passes through and what stays behind.¹ A protein called nephrin is a critical building block of this mesh, and mutations in nephrin cause massive protein leakage into the urine.²

The result is ultrafiltration: water, salts, glucose, amino acids, and small waste molecules pass through, while blood cells and large proteins like albumin are held back. This initial filtrate is not urine yet. It is essentially blood plasma minus the big molecules, and the kidneys would lose absurd amounts of glucose, salt, and water if the story ended there.

Reclaiming What the Body Needs

After filtration, the fluid enters a long, winding tubule where the real refinement happens. In the early part of the proximal tubule, specialized transporters actively grab glucose out of the filtrate and shuttle it back into the blood. About 97% of filtered glucose is recaptured in the first two segments of this tubule, and the remainder is mopped up further along.³ Sodium, bicarbonate, amino acids, and water are similarly reclaimed in a tightly regulated process. By the time the remaining fluid reaches the collecting duct, it has been concentrated into urine containing almost exclusively waste.

This two-step design, first filtering almost everything out and then selectively reabsorbing the good stuff, is a hallmark of mammalian kidneys. It gives the body fine-grained control over exactly what to keep and what to discard, something that no artificial filter has managed to replicate fully.

Keeping Filtration Steady Under Changing Conditions

Your blood pressure swings throughout the day. You stand up, you exercise, you eat a salty meal. Yet the kidneys maintain a remarkably stable filtration rate across a wide range of pressures, roughly 80 to 180 mmHg.⁴ They achieve this through autoregulation, an internal system that adjusts the diameter of the small artery feeding each glomerulus.

Two mechanisms dominate. One is a direct response of the artery wall to changes in pressure: when pressure rises, the artery constricts to protect the delicate glomerular capillaries. The other is a feedback loop where a specialized patch of cells in the tubule senses how much sodium and chloride is flowing past. If too much is arriving (suggesting the filtration rate is too high), it signals the artery to tighten up. Under resting conditions, the direct pressure response contributes roughly half of autoregulation, while the tubular feedback loop accounts for about 35 to 50%.⁵ There is also a second tubular feedback site, discovered more recently, where a different segment of the tubule contacts the same artery and provides an additional layer of fine-tuning.⁶

Diseases like diabetes and chronic hypertension gradually damage these autoregulatory mechanisms, meaning the glomeruli become exposed to uncontrolled pressure swings. Over years, that accelerates kidney damage, which is one reason blood pressure control is so critical for people with kidney disease.

The Spleen as a Blood Cell Filter

Your kidneys filter dissolved substances out of plasma. Your spleen does something different: it physically inspects red blood cells. Inside the spleen, blood flows through an open meshwork where red cells must squeeze through extremely narrow gaps, slits between the cells lining the vessel walls. These inter-endothelial slits are less than a micron wide, smaller than the red blood cell itself.⁷

A healthy red blood cell is flexible enough to fold itself in half and pop through. An aged, stiffened, or abnormally shaped cell cannot make it. Those cells get trapped and are eaten by immune cells called macrophages. This mechanical quality-control system runs continuously, clearing defective cells and maintaining the overall health of circulating blood.⁸ Computational models show that the spleen selects red blood cells based on their geometry: cells that are too round, too large, or too rigid are preferentially retained.⁹

This filtering role is especially relevant in diseases like sickle cell disease and malaria, where red blood cells are deformed. In sickle cell disease, the spleen works overtime early in life, sometimes destroying so many cells that it eventually scars itself shut. In malaria, the parasite stiffens the cells it infects, and the spleen traps and destroys many of them. Understanding the spleen’s physical filtration mechanism has become important for developing blood-based diagnostic markers for red cell disorders.

The Liver’s Role in Filtering Pathogens

The liver receives blood from the digestive tract before it enters general circulation. Sitting in the liver’s sinusoids are resident immune cells called Kupffer cells, which intercept bacteria, endotoxins, and debris that leak from the gut. Kupffer cells were long considered just a local filter for the portal blood supply, but more recent evidence shows they play a broader role in systemic defense against bacterial infection, cooperating with other immune cells to mount a coordinated response.¹⁰ The liver also chemically filters the blood by metabolizing drugs, alcohol, and hormones, converting them into forms that can be excreted by the kidneys or into bile.

When Kidneys Fail and Machines Take Over

If your kidneys lose most of their function, waste products and fluid build up fast enough to become life-threatening. Hemodialysis is the most common artificial substitute. Your blood flows through bundles of hollow synthetic fibers inside a device called a dialyzer, with a cleansing fluid called dialysate flowing on the outside. Small waste molecules like urea move from blood to dialysate by diffusion, driven by the concentration difference between the two sides.¹¹

Running blood and dialysate in opposite directions, the countercurrent arrangement, substantially improves waste removal. Modeling studies show that countercurrent flow nearly doubles urea clearance compared to running both fluids in the same direction.¹² Other factors like fiber diameter, fiber length, and flow rates all influence how much waste gets removed in a given session.¹³

Standard hemodialysis excels at removing small molecules but struggles with medium-sized ones. This has been a long-standing concern in nephrology, because some toxins believed to drive the complications of kidney failure are larger molecules that diffusion alone clears poorly.

Hemofiltration and Continuous Therapies for the Critically Ill

For patients in intensive care with acute kidney injury, standard intermittent hemodialysis can be too aggressive. Pulling fluid and waste rapidly from someone whose blood pressure is already fragile can cause dangerous drops. Continuous renal replacement therapy runs at gentler flow rates around the clock, giving the body time to equilibrate.

Some of these continuous therapies rely primarily on convection rather than diffusion. Instead of relying on a concentration gradient, the machine pushes plasma water through the membrane under pressure, dragging dissolved waste along with it. The filtered fluid is then replaced with a clean solution. Convective therapies were expected to clear medium-sized molecules more effectively, and in some settings they do: one study in critically ill patients found that convective clearance of a medium-sized marker (beta-2 microglobulin) trended higher than diffusive clearance, though the difference was not statistically significant.¹⁴ In vitro testing with larger dialyzers showed that convective and diffusive therapies produced nearly identical clearance of middle molecules up to 100 kDa.¹⁵ The practical upshot is that dialyzer size and membrane characteristics may matter as much as the choice between convection and diffusion.

Plasma Exchange and Apheresis

Sometimes the problem is not small waste molecules at all, but large pathological proteins circulating in the blood. Autoantibodies, immune complexes, and inflammatory molecules can drive diseases ranging from Guillain-Barré syndrome to certain forms of vasculitis. Therapeutic plasma exchange physically removes the patient’s plasma, including those harmful proteins, and replaces it with donor plasma or an albumin solution.¹⁶

The technique works both by subtraction and by addition. Removing autoantibodies and inflammatory cytokines reduces the immune attack. And when full plasma is used as replacement fluid, it can also supply missing clotting factors or functional proteins the patient lacks.¹⁷ Plasma exchange is not a permanent fix; the body re-generates the removed proteins, so it typically needs to be repeated in a series alongside other treatments.

The Biocompatibility Problem

Passing blood over an artificial surface is inherently unnatural, and the body reacts accordingly. When blood contacts the synthetic membranes used in dialyzers, plasma proteins like albumin and fibrinogen immediately stick to the surface. Some of those adsorbed proteins change shape in ways that trigger the complement system, a branch of the immune system that evolved to recognize foreign surfaces. The result is activation of white blood cells and release of inflammatory signaling molecules.¹⁸ This happens every dialysis session, which means patients on long-term hemodialysis endure a chronic state of low-grade inflammation on top of whatever inflammation their kidney disease already causes.¹⁹

The original dialysis membranes, made from cellophane, were particularly inflammatory. Over the decades, the field moved to modified cellulosic and then fully synthetic membranes that trigger less complement activation.²⁰ Modern high-flux synthetic membranes are a significant improvement, but they have not eliminated the problem entirely. The search for truly biocompatible blood-contacting surfaces remains one of the central challenges of extracorporeal blood filtration.

Mechanical damage is another concern. Pumping blood through tubing and past artificial surfaces exposes platelets to shear forces they do not encounter in normal circulation. Over time, platelets become activated and lose surface receptors, which impairs their ability to form clots normally. High-molecular-weight forms of an important clotting protein (von Willebrand factor) also degrade during circulation through extracorporeal circuits.²¹ These effects contribute to the bleeding complications that can occur in patients on continuous blood-purification therapies.

Keeping the Circuit From Clotting

Blood that contacts artificial surfaces wants to clot. Without anticoagulation, dialysis filters clog within hours, cutting the treatment short. The two main strategies are systemic heparin, which thins the blood throughout the body, and regional citrate, which chelates calcium (an essential ingredient for clotting) only inside the circuit, then calcium is infused back into the patient afterward.

A large randomized trial compared the two approaches in critically ill patients on continuous kidney replacement therapy. Filters lasted substantially longer with citrate anticoagulation: a median of 47 hours versus 26 hours with heparin. Bleeding complications were also about three times less common with citrate. However, the citrate group had a higher rate of new infections, something still debated in the literature.²² A meta-analysis of randomized trials broadly confirmed the bleeding advantage of citrate but noted that low calcium levels were more common, requiring monitoring to avoid complications.²³ In practice, citrate has become the preferred choice in many ICUs, with heparin reserved for situations where citrate is not feasible, such as in patients with severe liver failure who cannot metabolize it.

Filtering Inflammation Itself During Sepsis

Sepsis is a runaway inflammatory response to infection, and a major killer in intensive care. One of the more experimental frontiers of blood filtration aims to remove the inflammatory molecules themselves rather than traditional kidney waste. Devices using sorbent beads or specialized membranes can pull cytokines, endotoxins, and other mediators directly from the bloodstream as blood is pumped through a cartridge.²⁴

Several commercial devices exist. One widely studied device uses polystyrene-based polymer beads designed to adsorb a range of inflammatory cytokines from the blood.²⁵ Newer cartridges using different sorbent materials have demonstrated significant reduction of endotoxin and key inflammatory cytokines in laboratory testing.²⁶ The concept is appealing, but the clinical evidence for improved survival in sepsis patients remains mixed. The inflammatory cascade in sepsis is extraordinarily complex, and removing a handful of circulating molecules may not be enough to reset it. Large, definitive trials are still ongoing or needed, and the field has learned to be cautious about early enthusiasm.

Peritoneal Dialysis and the Body’s Own Membrane

Not all artificial blood filtration requires pumping blood through a machine. In peritoneal dialysis, cleansing fluid is infused into the abdominal cavity, and the peritoneum, the thin membrane lining the abdomen, acts as the filter. Waste molecules cross from the blood in the peritoneal capillaries into the dialysis fluid by diffusion, while excess water is pulled across by the osmotic pull of glucose in the fluid.²⁷

The peritoneum has a unique transport property: it contains water-only channels (aquaporin-1) that let water pass without carrying dissolved molecules along. This was first noticed in the 1960s when researchers saw that solute sieving across the peritoneum was lower than expected. Over time, however, the peritoneal membrane changes. Fluid transport parameters, including the membrane’s ability to move water, decline with patient age and years on dialysis, while small-molecule transport rates stay relatively stable.²⁸ Monitoring those fluid transport changes over time helps clinicians decide when peritoneal dialysis is no longer working well enough.

Toward Implantable Artificial Kidneys

The holy grail of artificial blood filtration is a device small enough to implant in the body, freeing patients from machines entirely. Current research follows two tracks. One is purely engineering: creating silicon nanopore membranes with pores precise enough to mimic the kidney’s glomerular filter. The other is biological: lining those membranes or separate bioreactor cartridges with living human kidney cells that can perform the reabsorption and hormone production that synthetic membranes cannot.²⁹

Early bioartificial kidney prototypes combined a standard hemofilter with a cartridge housing roughly a billion human kidney tubule cells grown on the inner surfaces of hollow fibers.³⁰ More recently, a proof-of-concept implantable bioreactor using silicon nanopore membranes demonstrated that living renal cells could survive and function inside an implanted device, with the membranes providing enough immune shielding to protect the cells without immunosuppressive drugs.³¹ These are still early-stage demonstrations, not clinical products, but they represent real progress toward a future where dialysis machines are replaced by something that works inside the body continuously, the way a transplanted kidney would.

Microfluidic Blood Separation

Separate from the quest for a replacement kidney, miniaturized blood filtration is advancing rapidly in diagnostic and research applications. Microfluidic devices manipulate tiny volumes of blood on chips the size of a credit card, using channels so small that physical forces can sort cells by size, stiffness, or electrical properties without the need for chemical labels.³² One recent platform built on a spinning compact disc achieved over 99% efficiency in separating red cells, white cells, and platelets purely by size-based flow fractionation.³³

These devices are not designed to treat kidney failure. Their value lies in point-of-care diagnostics, rapid infection detection, and single-cell analysis. But the underlying engineering principles, using precisely controlled geometries to sort blood components without damaging them, inform the broader field of blood filtration design, including the miniaturized filters being developed for wearable and implantable artificial kidneys.

How Blood Filtration Varies Across Species

Humans are not unique in filtering blood through glomeruli. The basic glomerular filtration design is shared across vertebrates, from fish to birds. But how hard those kidneys work varies enormously. Warm-blooded animals, with their higher metabolic rates and more numerous glomeruli, filter proportionately more blood than cold-blooded ones. Among cold-blooded vertebrates, reptiles tend to have the lowest filtration rates, likely because many species live in environments where conserving water matters more than rapidly clearing waste.³⁴

Within any given class, access to water predicts kidney function. Freshwater fish filter far more blood than their saltwater relatives, because freshwater fish are constantly flooded with water through their gills and need to get rid of it. Desert-adapted mammals concentrate their urine to extremes that would damage human kidneys, using exceptionally long loops in their nephrons to wring every last drop of water back into the body. These comparative patterns underscore a point that applies to artificial filtration too: the job of a filter is always defined by the environment it serves, and the design constraints follow from there.